Consensus expectations for Amprius Technologies are for a loss of $0.01 per share on $35.80 million in revenue, while the stock trades at $8.90, significantly below the $21.42 average analyst target.
Investors are primarily focused on the company's gross margin expansion and its ability to scale domestic production via the new Nanotech Energy partnership. Supporting this outlook is a 126% revenue surge in the prior quarter and a raised fiscal year 2026 revenue guidance of at least $140 million. The market is particularly sensitive to the sustained demand from the defense sector, which recently accounted for over 30% of total sales.